# Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial

Article · David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker-Jones, David Nutt, Brandon Weiss, Robin Lester Carhart-Harris

- Archive id: doi:10.1016/j.eclinm.2024.102799
- Published: 2024-09-23
- Venue: EClinicalMedicine
- DOI: https://doi.org/10.1016/j.eclinm.2024.102799
- PMID: 39764567
- Citations: 57
- Source URL: https://doi.org/10.1016/j.eclinm.2024.102799
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Novel Psychiatric Therapeutics](https://space-kitty.com/topics/psychiatric-therapeutics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.